ARCHIVES

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

This article is from The Cancer Letter archive.

Vol. 28 No. 31 | August 2, 2002

Download PDF Visit The Full Archive

Related Articles

1981 Budget By Funding Mechanism

June 1, 1979

NCI May Give Up Positions From Other Programs To Meet Mandate For CTP Slots

October 19, 1979

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012